欧易生物是一家致力于为生命科学研究提供多组学技术的研究服务机构，产品涵盖 单细胞及时空多组学、基因组学、转录组学、表观组学、蛋白组学、代谢组学、生物信息学以及临床诊断产品开发 ，秉承 「以生物科技 成就他人 造福大众」 ...

Researchers are continuing to study nasopharyngeal carcinoma (NPC) to understand how it develops and what it responds to. Their goal is to provide better outcomes and possible prevention. NPC is a ...

Hypoxic Gene Expression Signature as a Predictor of Recurrence and Mortality in Early-Stage Non–Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy A study of 1,040 patients with ...

Genetic Signatures: CD44 Single-Nucleotide Polymorphisms Affect Cell Surface Expression and Elevate Risk in Head and Neck Squamous Cell Carcinoma Data were separated into two cohorts. The CRT-AC ...

(RTTNews) - Biopharmaceutical company Akeso Inc. (AKESF) said in a statement that its Penpulimab has been approved for the first-line treatment of recurrent or metastatic nasopharyngeal cancer or NPC, ...

In stage N0-1 nasopharyngeal cancer, elective upper-neck irradiation provides outcomes on par with whole-neck irradiation and with significantly lower rates of long-term toxicity, according to ...

Please provide your email address to receive an email when new articles are posted on . Patients with nasopharyngeal cancer who received morning radiotherapy survived longer than those treated later ...

Patients living with aggressive nasopharyngeal carcinoma (NPC) now have a new treatment option with the U.S. FDA approval of Junshi Biosciences Co. Ltd./Coherus Biosciences Inc.’s PD-1 inhibitor ...

In 2023, Singapore Armed Forces (SAF) regular, Yeo Fu Kiang 36, experienced a persistent blocked right ear after returning ...

Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in fewer than one person out of 100,000 worldwide each year. Locally advanced ...